Quantity | = | Concentration | x | Volume | x | Molecular Weight |
---|---|---|---|---|---|---|
= | x | x |
1) Click the Molarity Calculation Cart® button.
2) Specify the Concentration and Volume of your desired Molarity.
3) Click Calculate.
4) Your desired Quantity will be calculated and will be put under Quantity: (only for mg)
5) Click Add to Cart and then Proceed to checkout to complete the order. You will receive the quantity as you ordered as solvent-free form.
Alert: If you want to make a solution with a solvent (such DMSO), please add instructions in the notes section (such as 10 nM/1 mL in DMSO) and we will pack and deliver the product as a solution (such as 10 nM solution in 1 mL DMSO). If the product cannot be dissolved in DMSO or you would like to specify your own preferred solvent, please add detailed instructions in the notes section. All solutions must be shipped with an ice bag, costing an additional fee of $20 for S&H.
AT10464L
Warning: Last items in stock!
Availability date:
Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
---|---|---|---|
1 | 100 | $31.05 | Total: $3,105.00 |
1 | 50 | $35.88 | Total: $1,794.00 |
1 | 25 | $42.09 | Total: $1,052.25 |
1 | 10 | $49.68 | Total: $496.80 |
1 | 5 | $58.65 | Total: $293.25 |
Molecular Formula | C18H18FN5O2S |
Molecular Weight | 387.43 |
CAS Numbers | 1414943-88-6 |
Storage Condition | 0C Short Term, -20C Long Term |
Solubility | DMSO |
Purity | 98% by HPLC |
SMILES Code | COc1cc(F)ccc1-c1ncnc(Nc2cccc(CS(C)(=N)=O)c2)n1 |
References | Scholz A, et al. BAY 1143572, a first-in-class, highly selective, potent and orally available inhibitor of PTEFbCDK9 currently in Phase I, shows convincing anti-tumor activity in preclinical models of acute myeloid leukemia [AML]. [abstract]. In Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia [PA] AACR; Cancer Res 2016;76[14 Suppl] Abstract nr 3022. |